CHARLOTTE, N.C., June 1 /PRNewswire-FirstCall/ -- MedCath Corporation (NASDAQ:MDTH) announced today that it has named a 26-year hospital veteran to the new position of Vice President, Quality and Clinical Process Improvement and hired an industry veteran to the new position of general counsel. Blair W. Todt becomes Vice President and General Counsel, responsible for directing legal operations of corporation, including joint ventures, mergers and acquisitions, healthcare law and regulatory compliance, litigation management, employment matters, and contract negotiation and administration. Kevin Andrews becomes responsible for quality management, regulatory compliance, infection control, case management, and patient satisfaction. Andrews joins MedCath from Universal Health Services, where he had been the Director, Quality Management and Performance Improvement for the company's Acute Care Hospital Division for the past four years. At Universal Health Services, Andrews was responsible for all acute care quality measurement and monitoring, utilization and case management, clinical consulting services, regulatory compliance, and patient satisfaction. "As we continue to expand our core services in heart care and diversify our service lines, it is important that we continue the MedCath legacy of quality excellence in all our services," said O. Edwin French, President and Chief Executive Officer of MedCath. "Having Kevin's skills in all areas of acute care will materially supplement our quality management competencies for data management and process improvement in heart care and the diversified services we find increasingly prevalent in many of our current hospitals and planned acute care expansions." Andrews is a graduate of Concordia University in River Forest, Ill. He also holds two master's degrees: in human services, counseling and community organization from Concordia, and in social work and health care administration from Aurora University in Aurora, Ill. He has worked in hospitals for 26 years, including service in quality management and clinical process improvement. Before joining MedCath, Todt had been Associate General Counsel at BearingPoint, Inc., a management and technology consulting firm, providing counsel to the Public Services and Healthcare practice groups in regulatory compliance, direction of responses to government inquiries, litigation management, and engagement review. In addition, Todt participated in the formation of BearingPoint's Office of Chief Compliance Officer, including creation and implementation of regulatory, ethics, privacy, and human resources training programs worldwide. Prior to joining BearingPoint, Todt was partner in the law firm of Carter, Conboy, Case, Blackmore, Maloney, & Laird, representing, among others, institutional and individual healthcare providers in all areas of healthcare law and litigation. Todt graduated from George Washington University and Brooklyn Law School. "Blair's vast experience in all areas of regulatory compliance and his varied healthcare experience are extremely valuable assets to our management team," French said. "We are delighted to welcome Blair to MedCath." MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates eleven hospitals with a total of 667 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners manage the cardiovascular program at various hospitals and provide services in diagnostic and therapeutic facilities in various states. DATASOURCE: MedCath Corporation CONTACT: O. Edwin French, President & Chief Executive Officer, or James E. Harris, Chief Financial Officer, +1-704-708-6600, both of MedCath Corporation Web site: http://www.medcath.com/

Copyright

Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Medcath Charts.
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Medcath Charts.